LOPETUSO, LORIS RICCARDO
 Distribuzione geografica
Continente #
AS - Asia 911
NA - Nord America 908
EU - Europa 644
Continente sconosciuto - Info sul continente non disponibili 211
SA - Sud America 176
AF - Africa 18
OC - Oceania 3
Totale 2.871
Nazione #
US - Stati Uniti d'America 821
IT - Italia 431
BD - Bangladesh 368
CN - Cina 136
BR - Brasile 130
SG - Singapore 130
VN - Vietnam 104
DE - Germania 100
HK - Hong Kong 92
CA - Canada 46
FR - Francia 36
KR - Corea 29
GB - Regno Unito 20
AR - Argentina 18
MX - Messico 15
EC - Ecuador 14
NL - Olanda 13
ID - Indonesia 12
IN - India 11
PL - Polonia 11
NO - Norvegia 6
CR - Costa Rica 5
CO - Colombia 4
HN - Honduras 4
PK - Pakistan 4
RU - Federazione Russa 4
TR - Turchia 4
UA - Ucraina 4
AU - Australia 3
BG - Bulgaria 3
ES - Italia 3
JM - Giamaica 3
MA - Marocco 3
PE - Perù 3
SA - Arabia Saudita 3
SN - Senegal 3
SV - El Salvador 3
UY - Uruguay 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EG - Egitto 2
GT - Guatemala 2
HR - Croazia 2
IE - Irlanda 2
IQ - Iraq 2
JP - Giappone 2
NI - Nicaragua 2
NP - Nepal 2
RO - Romania 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
AL - Albania 1
BM - Bermuda 1
BO - Bolivia 1
CY - Cipro 1
EE - Estonia 1
FI - Finlandia 1
GE - Georgia 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
MT - Malta 1
MZ - Mozambico 1
NG - Nigeria 1
PH - Filippine 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
VC - Saint Vincent e Grenadine 1
VE - Venezuela 1
Totale 2.660
Città #
San Jose 113
Frankfurt am Main 94
Hong Kong 90
Ashburn 72
New York 70
Rome 55
Santa Clara 54
Milan 53
Singapore 52
Beijing 48
Ho Chi Minh City 37
Hanoi 30
Seoul 28
Los Angeles 25
Naples 25
Council Bluffs 24
Princeton 21
Dallas 19
Toronto 18
Abbeville 17
Buffalo 17
Chicago 17
Florence 14
Bologna 10
Genoa 10
Mexico City 10
Hillsboro 9
Palermo 9
São Paulo 9
Warsaw 9
Padua 8
Pescara 7
Bari 6
Boston 6
Charlotte 6
Figino 6
Guayaquil 6
Oslo 6
Turin 6
Brasília 5
Brescia 5
Philadelphia 5
Phoenix 5
Seattle 5
Biên Hòa 4
Bắc Ninh 4
Cagliari 4
Campinas 4
London 4
Perugia 4
Porto Alegre 4
Rio de Janeiro 4
Venice 4
Verona 4
Washington 4
Amsterdam 3
Bexley 3
Brooklyn 3
Catania 3
Da Nang 3
Dakar 3
Goiânia 3
Haiphong 3
Lucca 3
Montreal 3
Quito 3
Ribeirão Preto 3
Roubaix 3
San José 3
San Pedro Sula 3
Tashkent 3
The Bronx 3
Trieste 3
Augusta 2
Bahía Blanca 2
Bergamo 2
Birmingham 2
Bogotá 2
Brandon 2
Brownsville 2
Carrollton 2
Caxias do Sul 2
Columbia 2
Denver 2
Fermo 2
Giugliano in Campania 2
Greenville 2
Guarulhos 2
Guatemala City 2
Ha Long 2
Houston 2
Jacksonville 2
Jakarta 2
Johannesburg 2
Joinville 2
Kyiv 2
La Joya de Los Sachas 2
Lahore 2
Leeds 2
Limburg an der Lahn 2
Totale 1.293
Nome #
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 112
Changes in the intestinal microbiota in patients with a major depressive episode and ulcerative colitis 90
Escherichia coli nissle 1917 modulate gut microbiota composition in ulcerative colitis patients 60
Impact of Psychopathology and Gut Microbiota on Disease Progression in Ulcerative Colitis: A Five-Year Follow-Up Study 60
Interleukin-23 Inhibitors in Inflammatory Bowel Disease 59
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 59
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 55
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 54
Bowel urgency in inflammatory bowel disease: A concept analysis 54
Resilience and Self-Care in Patients with Inflammatory Bowel Disease: A Multicentre Cross-Sectional Study in Outpatient Settings 54
Solute Transporter OCTN1/Slc22a4 Affects Disease Severity and Response to Infliximab in Experimental Colitis: Role of Gut Microbiota and Immune Modulation 52
Abdominal and Bowel Ultrasound Knowledge Among Young Gastroenterologists: Results of an Italian Survey 50
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 47
Emerging Role of Gut Microbiota in Modulating Response to Therapies in IBD 46
Gut microbiota profiling and gut-brain crosstalk in children affected by pediatric acute-onset neuropsychiatric syndrome and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections 46
A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factors 44
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 42
Bacillus clausii and gut homeostasis: state of the art and future perspectives 41
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 40
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 40
Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis 38
Harmful effects and potential benefits of anti-tumor necrosis factor (TNF)-α on the liver 38
Psychopharmacological Therapy Positively Modulates Disease Activity in Inflammatory Bowel Disease: A Systematic Review 38
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 36
Angiotensin‐converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID‐19 34
Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila 32
Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis 30
Risk of burnout and stress in physicians working in a COVID team: A longitudinal survey 30
Mapping Competence in Gastrointestinal Endoscopy Nursing Practice: An Item Response Theory Analysis of Perceived Skill Acquisition and Maintenance in Italy 29
European Crohn's and colitis organisation topical review on treatment withdrawal ['exit strategies'] in inflammatory bowel disease 29
A novel model of colitis-associated cancer in SAMP1/YitFc mice with Crohn's disease-like ileitis 29
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 29
COVID-19 and intestinal inflammation: Role of fecal calprotectin 28
Role of Helicobacter pylori infection on nutrition and metabolism 28
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 27
Gut microbiota during dietary restrictions: New insights in non-communicable diseases 27
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 26
Orphan patients with inflammatory bowel disease - when we treat beyond evidence 26
The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn’s disease 26
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 25
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: An update 25
Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists 25
European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus 25
Infliximab does not increase colonic cancer risk associated to murine chronic colitis 24
Assessment of neurological manifestations in hospitalized patients with COVID‐19 23
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases 22
Characterization of sarcopenia in an IBD population attending an Italian gastroenterology tertiary center 22
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis 21
Liver involvement is not associated with mortality: results from a large cohort of SARS‐CoV‐2‐positive patients 19
Predicting In‐Hospital Mortality in COVID‐19 Older Patients with Specifically Developed Scores 18
Can we predict the efficacy of anti-TNF-α agents? 18
Bariatric procedures and microbiota: patient selection and outcome prediction 18
Beyond the HLA Genes in Gluten-Related Disorders 18
Assessment of crohn’s disease activity: Magnetic resonance enterography in comparison with clinical and endoscopic evaluations 17
OCTN1 variants shape innate immunity and predict individual response to anti-TNFα in ulcerative colitis patients: An exploratory study 17
Epidemiology of inflammatory bowel disease in the Republic of San Marino: The “EPIMICI – San Marino” study 16
Proteobacteria: A common factor in human diseases 15
Hypoxic Functional Regulation Pathways in the GI Tract: Focus on the HIF-1α and Microbiota's Crosstalk 15
A modern multidisciplinary approach to the treatment of enterocutaneous fistulas in Crohn’s disease patients 15
The Heart–Gut Axis in Heart Failure: The Role of Next-Generation Pharmacological Therapies 15
Epithelial-specific Toll-like Receptor (TLR)5 Activation Mediates Barrier Dysfunction in Experimental Ileitis 14
Bacteriocins and bacteriophages: Therapeutic weapons for gastrointestinal diseases? 14
Akkermansia muciniphila: Key player in metabolic and gastrointestinal disorders 14
Clinical Predictive Factors for the Development of Short Bowel Syndrome in a Cohort of Patients with Crohn’s Disease: A Prospective Study 14
MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer 13
Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period 13
Gut microbiota and inflammatory bowel disease: So far so gut! 13
Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications 13
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 13
Endoscopic Management of Strictures in Crohn's Disease: An Unsolved Case 13
Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis 13
Fecal microbiota transplantation in murine models of colitis and short bowel syndrome: lessons learned, limitations, and translational perspectives 13
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 13
Prognostic performance of the 'DICA' endoscopic classification and the 'CODA' score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort study 12
Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? 12
Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission 12
Commentary to “safety, clinical response, and microbiome findings following fecal microbiota transplant in children with inflammatory bowel disease” 12
How to face the advent of sars-cov-2 vaccination in ibd patients: Another task for gastroenterologists 11
Multimodal dynamic ultrasound approach as predictor of response in patients with Crohn’s disease treated with ustekinumab 11
The use of probiotics in different phases of diverticular disease 11
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review 10
Intestinal inflammation and microbiota modulation impact cochlear function: emerging insights in gut-ear axis 10
13C-octanoic acid breath test to study gastric emptying time 10
Inflammatory bowel disease (IBD) is associated with increased intestinal extrachromosomal circular DNA: an emerging biomarker for IBD type and activity 10
Future challenges in gastroenterology and hepatology, between innovations and unmet needs: A SIGE Young Editorial Board's perspective 10
Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape 10
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 9
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 9
Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach 9
Ecological patterns of the gut mycobiome and microbiome in ulcerative colitis across life stages 9
Actinobacteria: A relevant minority for the maintenance of gut homeostasis 9
The therapeutic management of gut barrier leaking: The emerging role for mucosal barrier protectors 9
Gelatin tannate and tyndallized probiotics: a novel approach for treatment of diarrhea 9
Fecal transplantation for ulcerative colitis: current evidence and future applications 9
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 9
Prevalence of cervical HPV and attitude towards cervical screening in IBD patients under immunomodulatory treatment: A multidisciplinary management experience 8
High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. Pylori infection 8
Prevalence of severe irritable bowel syndrome among Italian adults. A meta-analysis 8
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises from a First Meta-Analysis 8
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 8
Totale 2.533
Categoria #
all - tutte 31.178
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.178


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202597 0 0 0 0 0 0 0 7 8 29 37 16
2025/20262.039 51 50 105 134 89 47 63 160 212 326 458 344
2026/2027735 105 308 142 180 0 0 0 0 0 0 0 0
Totale 2.871